LightNews — News, ranked by scholars

@mcphersoneri.bsky.social

Last weekend, the McPherson ERI was proud to co-sponsor the inaugural Midwest Retina Neurobiology Workshop! We’re excited to see the Midwest retina neurobiology community continue to grow!

#RetinaResearch #VisionScience #UWMadison #Neuroscience #ScienceCommunity

September 30, 2026 at 1:01 PM

McPherson Eye Research Institute

@mcphersoneri.bsky.social

What are ‘ribbons’ doing in your eye?! A recent study by Sinha and Hoon labs uncovers new role(s) of these molecular components that fuel retinal visual processing. See the post here: buff.ly/go4kaVN
Research article here: buff.ly/PisN58x
#VisionScience #RetinaResearch #Neuroscience #Synapses #PNAS

September 25, 2026 at 4:48 PM

Communications Medicine

@commsmed.nature.com

🚨 NEW research⚕️ 🩺

http://dlvr.it/TVPxTW

Pu et al. examine retinal and used a computer-assisted tool to map hard drusen across different regions of the retina. #AgeRelatedMacularDegeneration #RetinaResearch

Indocyanine green angiography and machine learning analysis determine topographic distribution of peripheral hard drusen in a Chinese cohort - Communications Medicine

Pu et al. use machine learning to quantify peripheral hard drusen across nine retinal quadrants in 1,562 normal eyes using indocyanine green angiography. Nasal quadrants show earlier and greater drusen accumulation, and central superior drusen count independently predicts progression to neovascular age-related macular degeneration.

dlvr.it

September 10, 2026 at 7:30 AM

Optometry Advisor

@optometryadvisor.bsky.social

The FDA (@fda.gov) has approved Lytenava™ (bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration (wet AMD).

Learn more: https://bit.ly/4qYjzbT

#WetAMD #RetinaResearch #Optometry

FDA Alerts: New Optometry Drugs and Devices

This roundup highlights recent FDA updates related to drug approvals and devices used by optometric eye care professionals.

bit.ly

August 19, 2026 at 10:52 PM

retina_int

@retinaint.bsky.social

We're pleased to share that our research has been published in the #ARVO2026 Annual Meeting Abstract Issue.

The study explores the link between visual acuity and cognitive performance, contributing to a better understanding of vision health and healthy ageing.

#VisionResearch #RetinaResearch

Graphic announcing a newly published ARVO 2026 abstract titled Association Between Visual Acuity and Cognitive Performance: Evidence from The Irish Longitudinal Study on Ageing (TILDA), with a QR code linking to the abstract.

July 15, 2026 at 10:42 AM

retina_int

@retinaint.bsky.social

Congratulations to Prof. José-Alain Sahel, Chair of Retina International's Scientific & Medical Advisory Board, on receiving the 2024 Wolf Prize in Medicine alongside Prof. Botond Roska for their pioneering work in optogenetics and vision restoration.

#WolfPrize #RetinaResearch #VisionResearch

June 29, 2026 at 12:09 PM

retina_int

@retinaint.bsky.social

Check out our dedicated Clinical Trials Resources page featuring registries, expert-curated databases, and trusted global resources for the inherited retinal disease community.

retina-international.org/clinical-tri...

#RareDiseases #ClinicalTrials #RetinaResearch #InheritedRetinalDiseases

retina-international.org

May 20, 2026 at 10:22 AM

retina_int

@retinaint.bsky.social

At @arvoinfo.bsky.social‬ Annual Meeting 2026, Dr Kate Fankun Cao from RI shared new findings exploring this link, using data from TILDA.

Part of Retina International’s ongoing work to turn lived experience into evidence that shapes better care.

#ARVO2026 #RetinaResearch #EyeHealth

[ID: Wide shot of a conference room at the ARVO. Attendees are facing the stage where a presentation slide titled “Results - Vision & Cognition”. The slide includes charts and graphs. Kate stands at a podium on the right. The image is framed with a blue Retina International branded border and the text “#ARVO2026” at the top.]

[ID: Close-up of Kate presenting at the ARVO 2026 Annual Meeting at a podium. The image is framed with a yellow Retina International branded border and the text “#ARVO2026” at the top.]

[ID: Wide shot of a conference session at the ARVO. A presentation slide is projected on a large screen, while Kate stands at a podium to the right. The image is framed with a pink Retina International branded border and the text “#ARVO2026” at the top.]

May 6, 2026 at 2:02 PM

retina_int

@retinaint.bsky.social

Great to see the RI Chair, Franz Badura, at this year’s Potsdam Meeting, a standout event uniting the global retinal research community.

From genetics to new therapies, it spotlighted innovation and future researchers. Congrats to all involved!

#RetinaResearch #PotsdamMeeting #VisionResearch

Image description: Hélène Dollfus with Franz Badura at the Potsdam meeting. They are both smiling to camera, standing in front of posterboards at the conference venue.

April 22, 2026 at 10:49 AM

retina_int

@retinaint.bsky.social

How do we make GA clinical trials more patient-focused?
Join our virtual @arvoinfo.bsky.social SIG session:

June 10, 9-10:30am EDT.

Hosted by @retinaint.bsky.social - open discussion encouraged!

🔗 Register: www.arvo.org/education/sp...

#GeographicAtrophy #RetinaResearch #ClinicalTrials #AMD

Image 2: Dark grey poster with blue text. Panelists: Avril Daly, Dr. Andrew Want,Dr. Maximilian Pfau, Dr. Jane Moseley

May 21, 2025 at 9:59 AM

retina_int

@retinaint.bsky.social

Congratulations to FARPE on their 35th anniversary. As part of the celebration, they are organizing various activities to raise public awareness and continue driving scientific progress to improve prognosis and treatment of these diseases. youtube.com/shorts/teTjU... #RetinaResearch #IRD #35years

35 CUMPLEAÑOS FARPE #bajavisión #ceguera

YouTube video by Fundación Lucha Contra La Ceguera (FUNDALUCE)

youtube.com

February 11, 2025 at 9:55 AM

retina_int

@retinaint.bsky.social

Our colleagues in Retina New Zealand are hosting the Innovation in Retina Research Australasia event this coming Friday and Saturday. Registration details can be found in the following link retina.org.nz/front-page-p... #RetinaResearch #Innovation #AMD #IRD

retina.org.nz

February 10, 2025 at 10:40 AM

Optometry Advisor

@optometryadvisor.bsky.social

GLP-1 receptor agonists may be associated with a lower incidence of nonexudative #AMD, although the certainty of available evidence is very low, according to a systematic review in the Canadian Journal of Ophthalmology.

Learn more: https://bit.ly/4wZX5KL

#RetinaResearch

GLP-1 RA Use Not Consistently Associated With Increased AMD Risk

GLP-1 RAs are not consistently linked to an increased risk of AMD and may reduce nonexudative AMD incidence according to a systematic review.

bit.ly

July 22, 2026 at 9:35 PM

Optometry Advisor

@optometryadvisor.bsky.social

Older age and female sex are independently associated with reduced visual acuity among patients with treatment-naive #DiabeticMacularEdema (DME), according to research published in Acta Ophthalmologica.

Read more here: https://bit.ly/4yqbGkb

#RetinaResearch

Older Age, Female Sex Linked to Reduced Visual Acuity in Diabetic Macular Edema

Older age and female sex are independently associated with reduced visual acuity among treatment-naive patients with diabetic macular edema.

bit.ly

July 13, 2026 at 4:55 PM

Optometry Advisor

@optometryadvisor.bsky.social

Patient immune status plays a significant role in determining the clinical characteristics and long-term visual outcomes of #HerpesvirusRetinitis, according to research published in Ophthalmology Retina.

Learn more: https://bit.ly/4yczjfG

#RetinaResearch #RetinalDisease

Immune Status Influences Herpesvirus Retinitis Phenotypes, Visual Outcomes

Patient immune status is linked to distinct clinical phenotypes and visual outcomes in acute retinal necrosis and cytomegalovirus retinitis.

bit.ly

July 8, 2026 at 9:47 PM

Simon J. Clark

@prof-clark.bsky.social

🌍 Discover how mapping sialoglycoconjugates in the human retina opens new doors for ocular disease therapies buff.ly/YPEg5kj

#Ophthalmology #RetinaResearch #AMD #Biomarkers #TherapeuticInnovation #FutureOfMedicine

Sialoglycoconjugate Profiling of Human Choroid, Retinal Pigment Epithelium, and Basal Laminar Deposits - PubMed

buff.ly

September 2, 2025 at 11:01 AM

Simon J. Clark

@prof-clark.bsky.social

High-res, motion-corrected OCT enables precise tracking of subretinal drusenoid deposits in intermediate AMD. Most remain stable, but some regress, fuse, or newly form—enhancing biomarker analysis. 👁️🔬 #AMD #OCT #Imaging #RetinaResearch #Ophthalmology buff.ly/igXYP2C

High-Resolution, Motion-Corrected, Volume-Fused OCT for Investigating Longitudinal Changes in Subretinal Drusenoid Deposits in Intermediate AMD - PubMed

The methods presented have the potential to improve OCT analysis of focal features, such as quantification of SDDs and other AMD biomarkers.

buff.ly

June 16, 2025 at 2:04 AM

Grzegorz (Greg) Walkiewicz

@greg-walkiew.bsky.social

I'm excited to start my postdoc at @stanfordpress.bsky.social in the Department of Ophthalmology with Prof. Yang Sun. I'll continue my work on retinal pathology and neurodegeneration.

If you’re working on similar topics, let’s connect.

#Neurodegeneration #RetinaResearch #Alzheimer #science